Rein Therapeutics (RNTX) Working Capital

Annual Working Capital

$13.88 M
-$4.61 M-24.92%

December 1, 2023


Summary


Performance

RNTX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRNTXbalance sheetmetrics:

Quarterly Working Capital

$13.03 M
-$5.20 M-28.52%

September 1, 2024


Summary


Performance

RNTX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRNTXbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

RNTX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-24.9%+58.2%
3 y3 years+12.3%-8.4%
5 y5 years-15.4%-35.1%

RNTX Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-68.2%at low-70.2%-36.8%
5 y5-year-68.2%-10.9%-78.7%-42.1%
alltimeall time-70.4%-89.4%-78.7%-49.9%

Rein Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$13.03 M(-28.5%)
Jun 2024
-
$18.22 M(+121.4%)
Mar 2024
-
$8.23 M(-40.7%)
Dec 2023
$13.88 M(-24.9%)
$13.88 M(+24.3%)
Sep 2023
-
$11.17 M(-12.4%)
Jun 2023
-
$12.76 M(-10.3%)
Mar 2023
-
$14.22 M(-23.1%)
Dec 2022
$18.49 M(-57.7%)
$18.49 M(-17.9%)
Sep 2022
-
$22.52 M(-20.7%)
Jun 2022
-
$28.40 M(-20.8%)
Mar 2022
-
$35.85 M(-17.9%)
Dec 2021
$43.67 M(+253.1%)
$43.67 M(-12.4%)
Sep 2021
-
$49.86 M(-10.8%)
Jun 2021
-
$55.88 M(-8.8%)
Mar 2021
-
$61.25 M(+395.3%)
Dec 2020
$12.37 M
$12.37 M(+15.3%)
DateAnnualQuarterly
Sep 2020
-
$10.72 M(-27.3%)
Jun 2020
-
$14.74 M(+95.4%)
Mar 2020
-
$7.54 M(-45.0%)
Dec 2019
$13.71 M(-16.4%)
$13.71 M(-31.7%)
Sep 2019
-
$20.07 M(-26.1%)
Jun 2019
-
$27.17 M(+178.2%)
Mar 2019
-
$9.77 M(-40.5%)
Dec 2018
$16.41 M(-65.1%)
$16.41 M(-28.5%)
Sep 2018
-
$22.95 M(-25.6%)
Jun 2018
-
$30.84 M(-22.1%)
Mar 2018
-
$39.59 M(-15.7%)
Dec 2017
$46.95 M(+176.1%)
$46.95 M(-11.6%)
Sep 2017
-
$53.09 M(+714.2%)
Jun 2017
-
$6.52 M(-50.3%)
Mar 2017
-
$13.11 M(-22.9%)
Dec 2016
$17.00 M(+1051.1%)
$17.00 M
Dec 2015
$1.48 M
-

FAQ

  • What is Rein Therapeutics annual working capital?
  • What is the all time high annual working capital for Rein Therapeutics?
  • What is Rein Therapeutics annual working capital year-on-year change?
  • What is Rein Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Rein Therapeutics?
  • What is Rein Therapeutics quarterly working capital year-on-year change?

What is Rein Therapeutics annual working capital?

The current annual working capital of RNTX is $13.88 M

What is the all time high annual working capital for Rein Therapeutics?

Rein Therapeutics all-time high annual working capital is $46.95 M

What is Rein Therapeutics annual working capital year-on-year change?

Over the past year, RNTX annual working capital has changed by -$4.61 M (-24.92%)

What is Rein Therapeutics quarterly working capital?

The current quarterly working capital of RNTX is $13.03 M

What is the all time high quarterly working capital for Rein Therapeutics?

Rein Therapeutics all-time high quarterly working capital is $61.25 M

What is Rein Therapeutics quarterly working capital year-on-year change?

Over the past year, RNTX quarterly working capital has changed by +$4.79 M (+58.22%)